Cargando…
Augmenting trabeculectomy in glaucoma with subconjunctival mitomycin C versus subconjunctival 5-fluorouracil: a randomized clinical trial
OBJECTIVE: The aim of this study was to compare the efficacy of augmenting trabeculectomy with subconjunctival mitomycin C (TMMC) versus 5-fluorouracil (T5-FU) in lowering intraocular pressure (IOP). METHODS: Forty eyes from 40 patients referred to the Nikoukari Ophthalmology University Hospital, Ta...
Autor principal: | Mostafaei, Ali |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3090304/ https://www.ncbi.nlm.nih.gov/pubmed/21573097 http://dx.doi.org/10.2147/OPTH.S17328 |
Ejemplares similares
-
Low-dose subconjunctival bevacizumab to augment trabeculectomy for glaucoma
por: Sedghipour, Mohammad-Reza, et al.
Publicado: (2011) -
Subconjunctival bevacizumab to augment trabeculectomy with mitomycin C in the management of failed glaucoma surgery
por: Saeed, Ahmed M, et al.
Publicado: (2014) -
Comparison of Subconjunctival Mitomycin C and 5-Fluorouracil Injection for Needle Revision of Early Failed Trabeculectomy Blebs
por: Liu, Wei, et al.
Publicado: (2016) -
Topical Mitomycin-C versus Subconjunctival 5-Fluorouracil for Management of Bleb Failure
por: Pakravan, Mohammad, et al.
Publicado: (2011) -
Efficacy of Adjunctive Subconjunctival Bevacizumab on the Outcomes of Primary Trabeculectomy With Mitomycin C: A Prospective Randomized Placebo-controlled Trial
por: Kiddee, Weerawat, et al.
Publicado: (2015)